selective, pseudo-irreversible inhibitor of butyrylcholinesterase (IC50 = 455 nM). Inhibit aggregation of amyloid-beta in vitro 68% at 10 microM. 5-HT6R antagonist Ki 15 nM
Type : Derivative of Rivastigmine,Multitarget,5-HT-receptor-ligand,Sulfur Compound,Sulfonamide,Indole,Carbamate,Alkyl linked bis-ligand,anti-Abeta-aggregation
Chemical_Nomenclature : 3-(((2-((2-((1-(Phenylsulfonyl)-1H-indol-4-yl)oxy)ethyl)amino)ethyl)amino)methyl)phenyl ethyl(methyl)carbamate
Canonical SMILES : C1(=CC=CC2=C1C=C[N]2[S](=O)(=O)C3=CC=CC=C3)OCCNCCNCC4=CC(=CC=C4)OC(=O)N(C)CC
InChI : InChI=1S\/C29H34N4O5S\/c1-3-32(2)29(34)38-24-10-7-9-23(21-24)22-31-17-16-30-18-20-37-28-14-8-13-27-26(28)15-19-33(27)39(35,36)25-11-5-4-6-12-25\/h4-15,19,21,30-31H,3,16-18,20,22H2,1-2H3
InChIKey : ICTMWXFVTKPBCM-UHFFFAOYSA-N
Other name(s) :
Families : Cpd35-Rivastigmine-5-HT6 ligand of proteins in family
BCHE
Title : Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT(6) receptor with anti-aggregation properties against amyloid-beta and tau - Wichur_2021_Eur.J.Med.Chem_225_113783 |
Author(s) : Wichur T , Pasieka A , Godyn J , Panek D , Goral I , Latacz G , Honkisz-Orzechowska E , Bucki A , Siwek A , Gluch-Lutwin M , Knez D , Brazzolotto X , Gobec S , Kolaczkowski M , Sabate R , Malawska B , Wieckowska A |
Ref : Eur Journal of Medicinal Chemistry , 225 :113783 , 2021 |
Abstract : Wichur_2021_Eur.J.Med.Chem_225_113783 |
ESTHER : Wichur_2021_Eur.J.Med.Chem_225_113783 |
PubMedSearch : Wichur_2021_Eur.J.Med.Chem_225_113783 |
PubMedID: 34461507 |
Array ( [id] => 1725 [inhibitor] => Cpd35-Rivastigmine-5-HT6 [type] => Array ( [0] => Derivative of Rivastigmine [1] => Multitarget [2] => 5-HT-receptor-ligand [3] => Sulfur Compound [4] => Sulfonamide [5] => Indole [6] => Carbamate [7] => Alkyl linked bis-ligand [8] => anti-Abeta-aggregation ) [other_name] => Array ( ) [chemical_nomenclature] => 3-(((2-((2-((1-(Phenylsulfonyl)-1H-indol-4-yl)oxy)ethyl)amino)ethyl)amino)methyl)phenyl ethyl(methyl)carbamate [formula] => C29H34N4O5S [cas_number] => [mw] => 550.67 [pick_me_to_call] => display_script [kinetic_parameter] => [paper] => Wichur_2021_Eur.J.Med.Chem_225_113783 [comment] => selective, pseudo-irreversible inhibitor of butyrylcholinesterase (IC50 = 455 nM). Inhibit aggregation of amyloid-beta in vitro 68\% at 10 microM. 5-HT6R antagonist Ki 15 nM [gene_locus] => [kin_inhibitor] => [cid] => [family] => BCHE [inchikey] => ICTMWXFVTKPBCM-UHFFFAOYSA-N [canonicalsmiles] => C1(=CC=CC2=C1C=C[N]2[S](=O)(=O)C3=CC=CC=C3)OCCNCCNCC4=CC(=CC=C4)OC(=O)N(C)CC [inchi] => InChI=1S\/C29H34N4O5S\/c1-3-32(2)29(34)38-24-10-7-9-23(21-24)22-31-17-16-30-18-20-37-28-14-8-13-27-26(28)15-19-33(27)39(35,36)25-11-5-4-6-12-25\/h4-15,19,21,30-31H,3,16-18,20,22H2,1-2H3 [wikipedia] => [iupharlig] => [structure] => [substrate] => [interact_gene_locus] => [mutation] => [comment2] => [extoxnet] => [news] => [theoretical_model] => )